Solitary acrometastasis of the phalanx as initial presentation of an oligometastatic Kirsten rat sarcoma viral oncogene homolog-mutated lung adenocarcinoma: a case report

被引:0
|
作者
Puscasu, Alexandra-Ioana [1 ]
Moinard-Butot, Fabien [1 ]
Antoni, Delphine [2 ]
Schott, Roland [1 ]
Somme, Laura [1 ]
机构
[1] Inst Cancerol Strasbourg Europe, Dept Med Oncol, 17 Rue Albert Calmette, F-67200 Strasbourg, France
[2] Inst Cancerol Strasbourg Europe, Radiat Oncol Dept, 17 Rue Albert Calmette, F-67200 Strasbourg, France
关键词
Acrometastasis; Oligometastatic lung adenocarcinoma; Phalanx metastasis; METASTASIS;
D O I
10.1186/s13256-023-04127-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundAcrometastasis is an uncommon finding in non-small cell lung cancer and is usually a sign of multimetastatic disease. Few case reports have suggested solitary digital metastasis as the single secondary lesion of oligometastatic non-small cell lung cancer.Case presentationThis case report describes an unusual presentation of a Kirsten rat sarcoma viral oncogene homolog-mutated lung adenocarcinoma with a solitary bone metastasis in the fourth finger medial phalanx, which was also the first sign of the disease, in a 63-year-old Caucasian female patient. Digital surgical amputation was performed. After histopathological confirmation and radiological exclusion of other secondary lesions, chemoimmunotherapy in a first-line setting was initiated. A partial metabolic response in the primary lung lesion was observed after four cycles. Maintenance therapy is currently being continued.ConclusionSolitary digital metastasis is a rare finding in non-small cell lung cancer. Further studies are needed to investigate the mechanisms behind this particular dissemination process.
引用
收藏
页数:4
相关论文
共 19 条
  • [1] Solitary acrometastasis of the phalanx as initial presentation of an oligometastatic Kirsten rat sarcoma viral oncogene homolog-mutated lung adenocarcinoma: a case report
    Alexandra-Ioana Pușcașu
    Fabien Moinard-Butot
    Delphine Antoni
    Roland Schott
    Laura Somme
    Journal of Medical Case Reports, 17
  • [2] The prognostic value of Kirsten rat sarcoma viral oncogene homolog mutations in resected lung adenocarcinoma differs according to clinical features
    Ma, Zelin
    Zhang, Yang
    Deng, Chaoqiang
    Fu, Fangqiu
    Deng, Lin
    Li, Yuan
    Chen, Haiquan
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 163 (01): : E73 - E85
  • [3] Phase 1B Study of Momelotinib Combined With Trametinib in Metastatic, Kirsten Rat Sarcoma Viral Oncogene Homolog-Mutated Non-Small-Cell Lung Cancer After Platinum-Based Chemotherapy Treatment Failure
    Barbie, David A.
    Spira, Alexander
    Kelly, Karen
    Humeniuk, Rita
    Kawashima, Jun
    Kong, Shengchun
    Koczywas, Marianna
    CLINICAL LUNG CANCER, 2018, 19 (06) : E853 - E859
  • [4] Hepatic Rupture as the Initial Presentation of an EGFR-Mutated Lung Adenocarcinoma: A Case Report
    Mirallas, Oriol
    Bosch-Schips, Marc
    Pardo, Nuria
    Aubanell, Anton
    Salcedo-Allende, Maria Teresa
    Callejo, Ana
    Iranzo, Patricia
    Tabernero, Josep
    Felip, Enriqueta
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Complete response to nivolumab in Kirsten rat sarcoma virus oncogene KRAS-G12C mutant metastatic lung adenocarcinoma: a case report
    Jeffrey Mathew Boby
    Nurul Nadia Mohd Ghazali
    Anita Mani
    Mathew George
    Journal of Medical Case Reports, 16
  • [6] Complete response to nivolumab in Kirsten rat sarcoma virus oncogene KRAS-G12C mutant metastatic lung adenocarcinoma: a case report
    Boby, Jeffrey Mathew
    Ghazali, Nurul Nadia Mohd
    Mani, Anita
    George, Mathew
    JOURNAL OF MEDICAL CASE REPORTS, 2022, 16 (01)
  • [7] Association Between Computed Tomographic Features and Kirsten Rat Sarcoma Viral Oncogene Mutations in Patients With Stage I Lung Adenocarcinoma and Their Prognostic Value
    Wang, Hua
    Schabath, Matthew B.
    Liu, Ying
    Stringfield, Olya
    Balagurunathan, Yoganand
    Heine, John J.
    Eschrich, Steven A.
    Ye, Zhaoxiang
    Gillies, Robert J.
    CLINICAL LUNG CANCER, 2016, 17 (04) : 271 - 278
  • [8] Targeting Mutant Kirsten Rat Sarcoma Viral Oncogene Homolog in Non-Small Cell Lung Cancer: Current Difficulties, Integrative Treatments and Future Perspectives
    Li, Jia-Xin
    Li, Run-Ze
    Ma, Lin-Rui
    Wang, Peng
    Xu, Dong-Han
    Huang, Jie
    Li, Li-Qi
    Tang, Ling
    Xie, Ying
    Leung, Elaine Lai-Han
    Yan, Pei-Yu
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [9] Kirsten rat sarcoma viral oncogene homolog G12C mutant advanced non-small-cell lung cancer treated with MEK1/2 inhibitor trametinib: a case report
    Jiang, Ya
    Liu, Xin
    Lv, Dong-Lai
    Zhao, Xi-Long
    ANTI-CANCER DRUGS, 2022, 33 (01) : E752 - E755
  • [10] Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: A case report
    Rossing H.H.
    Grauslund M.
    Urbanska E.M.
    Melchior L.C.
    Rask C.K.
    Costa J.C.
    Skov B.G.
    Sørensen J.B.
    Santoni-Rugiu E.
    BMC Research Notes, 6 (1)